期刊论文详细信息
MOLECULAR AND CELLULAR ENDOCRINOLOGY 卷:299
Smoking and sVEGFR-1: Circulating maternal concentrations and placental expression
Article
Kaemaeraeinen, Meerit1  Soini, Tuuli1  Wathen, Katjoi-Anneli1  Leinonen, Elina1  Stenman, Ulf-Hakan2  Vuorela, Piia1 
[1] Univ Helsinki, Cent Hosp, Dept Obstet & Gynecol, Biomedicum, FIN-00290 Helsinki, Finland
[2] Univ Helsinki, Cent Hosp, Dept Clin Chem, Biomedicum, FIN-00290 Helsinki, Finland
关键词: sVEGFR-1;    sFIt-1;    Pre-eclampsia;    Smoking;    Pregnancy;    Placenta;   
DOI  :  10.1016/j.mce.2008.11.028
来源: Elsevier
PDF
【 摘 要 】

Smoking reduces the expression of VEGFR-1 in non-pregnant women. In pregnant women it reduces the risk of pre-eclampsia, which in turn is associated with increased placental expression of VEGFR-I and increased maternal circulating soluble VEGFR-I (sVEGFR-1). We therefore hypothesized that smoking might affect VEGFR-I expression in pregnant women. In maternal plasma sVEGFR-1 concentrations during the third trimester in both smoking (median 1088, range 834-1362 ng/L, n = 20) and non-smoking (728, 719-1336 ng/L, n = 19) women were higher than during the second trimester (smokers 374,291-683 ng/L, n = 6, p > 0.05; non-smokers 375, 290-667 ng/L, n = 22, p < 0.001). No difference was observed between smokers and non-smokers. Secretion of sVEGFR-1 into the culture medium, as well as the pattern and intensity of immunostaining in first trimester placenta were similar in tissue from smoking (n = 22) and non-smoking (n = 20) women. Thus, contrary to our hypothesis, smoking does not affect circulating maternal sVEGFR-1 concentrations or placental secretion of sVEGFR-1 or expression of VEGFR-I in vitro. (c) 2008 Elsevier Ireland Ltd. All rights reserved.

【 授权许可】

Free   

【 预 览 】
附件列表
Files Size Format View
10_1016_j_mce_2008_11_028.pdf 478KB PDF download
  文献评价指标  
  下载次数:23次 浏览次数:0次